The OCTANE analysis of 194 Ro telehealth patients was presented at EASD 2026. It had no comparison group, and patients who stopped treatment were left out.
Recap by typeshit. Full story at Patient Care Online.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
STAT reports from a peptide medicine conference where stem cell entrepreneur Chuck Meeker predicted FDA roundtables before year end. The FDA declined to comment.
Prosecutors say the fake pens came from China and hit over 150 pharmacies and businesses. One defendant was extradited from Italy, and each faces up to 71 years if convicted.
Loading…